Migraine Refills Online in California

Yes. California Business and Professions Code Section 2290.5 permits licensed physicians to prescribe appropriate medications via synchronous video telehealth. TeleDirectMD's California-licensed board-certified Family Medicine physician reviews your headache frequency, MIDAS or HIT-6 disability score, abortive medication response history, and medication overuse pattern before authorizing refills for established migraine. Triptans, gepants, antiemetics, and most preventive agents are in scope. Self pay is $79; Aetna is in-network effective April 30, 2026.

TeleDirectMD refills established migraine abortive medications including triptans (sumatriptan, rizatriptan, eletriptan, naratriptan, zolmitriptan, almotriptan) and gepants (ubrogepant, rimegepant), antiemetics (metoclopramide, ondansetron), and preventive agents including beta-blockers (propranolol, metoprolol), tricyclic antidepressants (amitriptyline), antiepileptics (topiramate), SNRIs (venlafaxine), and CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab) for patients already on established therapy.

Medication overuse headache (MOH), also called rebound headache, occurs when pain-relieving medications are used too frequently — triptans or ergotamines on ≥10 days/month, analgesics on ≥15 days/month — for more than 3 months. MOH transforms episodic migraine into chronic daily headache. The TeleDirectMD physician reviews your rescue medication use frequency at every visit. If MOH is suspected, the physician will discuss a withdrawal and prevention protocol rather than simply refilling high-frequency abortive medications.

Seek emergency care immediately for: thunderclap headache (worst headache of your life, sudden onset), headache with fever and neck stiffness (possible meningitis), headache with new focal neurologic deficits (weakness, vision loss, speech difficulty), headache after head trauma, or new headache in adults over 50. Severe status migrainosus lasting more than 72 hours also warrants urgent evaluation. These red-flag headaches require imaging or lumbar puncture that cannot be evaluated by video visit.

Abortive (acute) therapy treats an active migraine attack — triptans, gepants, NSAIDs, and antiemetics taken at onset of headache. Preventive (prophylactic) therapy is taken daily to reduce attack frequency, severity, and duration. Preventive therapy is indicated when attacks occur ≥4 days/month with disability, ≥8 days/month regardless of disability, or when acute medications are failing or overused. The AAN and American Headache Society recommend preventive therapy for these patients.

Generic triptan pricing with GoodRx coupons at California pharmacies (May 2026): generic sumatriptan 100 mg (9 tablets) approximately $20–$50; generic rizatriptan 10 mg (9 tablets) approximately $25–$60; generic eletriptan 40 mg (6 tablets) approximately $30–$80; generic naratriptan 2.5 mg (9 tablets) approximately $20–$40. New CGRP antagonist gepants (ubrogepant, rimegepant) remain expensive at $700–$1,100 for a 10-tablet supply — manufacturer savings programs and prior authorization assistance are available. Prescription cost is separate from the $79 TeleDirectMD visit fee.

Evidence-based preventive options per AAN Level A/B evidence include: propranolol ER 60–240 mg/day (Level A — also useful for comorbid hypertension), topiramate 25–100 mg BID (Level A — cognitive side effects; kidney stone risk in California's relatively dehydrated population), amitriptyline 10–75 mg at bedtime (Level B — also treats insomnia), valproate 500–1500 mg/day (Level A — teratogenic, avoid in women of childbearing potential), and venlafaxine 75–150 mg/day (Level B). CGRP monoclonal antibodies are Level A per AHS 2022 and represent first-line preventive therapy for episodic migraine with frequent attacks.

Yes. California Business and Professions Code Section 2290.5 does not require a prior in-person visit for telehealth prescribing of non-controlled medications. Triptans, gepants, antiemetics, and migraine preventives are not controlled substances and can be prescribed via a California video visit. The Medical Board of California holds telehealth physicians to the same standard of care as in-person physicians — which TeleDirectMD satisfies by conducting a thorough headache history and red-flag screening at every visit.

TeleDirectMD can refill established CGRP monoclonal antibody therapy (erenumab/Aimovig, fremanezumab/Ajovy, galcanezumab/Emgality) for patients already on a stable regimen with documented response. These agents require prior authorization from most California health plans. New starts for CGRP mAbs — particularly when several other preventives have not yet been tried — may benefit from neurologist or headache specialist consultation to document step therapy requirements.

The physician reviews triptan suitability at every visit, including: cardiovascular risk factors (triptans are contraindicated in uncontrolled hypertension, known coronary artery disease, stroke history, hemiplegic migraine, or basilar migraine), medication overuse pattern, triptan response history (which triptan formulation works best), and concomitant serotonergic medications (serotonin syndrome risk). Gepants (ubrogepant, rimegepant) are an alternative for patients with cardiovascular contraindications to triptans.

California Assembly Bill 744 (2019) requires commercial health plans to reimburse telehealth visits on the same basis as in-person visits. Aetna commercial plans are active in California as of April 30, 2026; UnitedHealthcare Commercial is approved effective May 29, 2026. Anthem Blue Cross and Cigna are pending. Prior authorization for CGRP mAbs may require additional documentation beyond the telehealth visit — the physician assists with prior auth documentation.

The physician reviews: headache frequency (days/month), severity, duration, associated symptoms, disability impact (MIDAS or HIT-6 questionnaire), current abortive medication use frequency and response, preventive medication adherence and side effects, red-flag symptom screening, and any new neurological symptoms since the last visit. Based on this review, the physician authorizes refills, considers step-up or step-down of therapy, and provides written follow-up instructions including when to seek emergency care. Self pay is $79; Aetna is in-network.